{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:53:31Z","timestamp":1793566411066,"version":"4.5.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T00:00:00Z","timestamp":1455667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00296-016-3435-1","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T03:54:08Z","timestamp":1455681248000},"page":"151-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga Prasanna","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjan N.","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,17]]},"reference":[{"key":"3435_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/157016110791330852","volume":"8","author":"AY Gasparyan","year":"2010","unstructured":"Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP et al (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8:437\u2013449","journal-title":"Curr Vasc Pharmacol"},{"key":"3435_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311. doi: 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"3435_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. doi: 10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"3435_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijcard.2015.06.087","volume":"199","author":"MR Hazebroek","year":"2015","unstructured":"Hazebroek MR, Kemna MJ, Schalla S et al (2015) Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol 199:170\u2013179. doi: 10.1016\/j.ijcard.2015.06.087","journal-title":"Int J Cardiol"},{"key":"3435_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R et al (2011) The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90:19\u201327. doi: 10.1097\/MD.0b013e318205a4c6","journal-title":"Medicine (Baltimore)"},{"key":"3435_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.07.009","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Lu N, Unizony S, Stone JH, Choi HK (2015) Improved survival in granulomatosis with polyangiitis: a general population-based study. Semin Arthritis Rheum. doi: 10.1016\/j.semarthrit.2015.07.009","journal-title":"Semin Arthritis Rheum"},{"key":"3435_CR7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3899\/jrheum.141513","volume":"42","author":"L McGeoch","year":"2015","unstructured":"McGeoch L, Carette S, Cuthbertson D et al (2015) Cardiac involvement in granulomatosis with polyangiitis. J Rheumatol 42:1209\u20131212. doi: 10.3899\/jrheum.141513","journal-title":"J Rheumatol"},{"key":"3435_CR8","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/rheumatology\/keq244","volume":"49","author":"C Pierrot-Deseilligny Despujol","year":"2010","unstructured":"Pierrot-Deseilligny Despujol C, Pouchot J, Pagnoux C, Coste J, Guillevin L (2010) Predictors at diagnosis of a first Wegener\u2019s granulomatosis relapse after obtaining complete remission. Rheumatology (Oxford) 49:2181\u20132190. doi: 10.1093\/rheumatology\/keq244","journal-title":"Rheumatology (Oxford)"},{"key":"3435_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2474-12-50","volume":"12","author":"C Lacoste","year":"2011","unstructured":"Lacoste C, Mansencal N, M Ben M\u2019rad et al (2011) Valvular involvement in ANCA-associated systemic vasculitis: a case report and literature review. BMC Musculoskelet Disord 12:50. doi: 10.1186\/1471-2474-12-50","journal-title":"BMC Musculoskelet Disord"},{"key":"3435_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.humpath.2011.04.020","volume":"43","author":"R Singh","year":"2012","unstructured":"Singh R, Rosen S (2012) Tumor of the heart in a young woman; a rare manifestation of Wegener granulomatosis. Hum Pathol 43:289\u2013292. doi: 10.1016\/j.humpath.2011.04.020","journal-title":"Hum Pathol"},{"key":"3435_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/0049475515624031","author":"DP Misra","year":"2016","unstructured":"Misra DP, Chowdhury AC, Edavalath S et al (2016) Endocarditis: the great mimic of rheumatic diseases. Trop Doct. doi: 10.1177\/0049475515624031","journal-title":"Trop Doct"},{"key":"3435_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1540-8175.2012.01699.x","volume":"29","author":"T Miszalski-Jamka","year":"2012","unstructured":"Miszalski-Jamka T, Szczeklik W, Nycz K et al (2012) Two-dimensional speckle-tracking echocardiography reveals systolic abnormalities in granulomatosis with polyangiitis (Wegener\u2019s). Echocardiography 29:803\u2013809. doi: 10.1111\/j.1540-8175.2012.01699.x","journal-title":"Echocardiography"},{"key":"3435_CR13","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10554-012-0158-6","volume":"29","author":"T Miszalski-Jamka","year":"2013","unstructured":"Miszalski-Jamka T, Szczeklik W, Sokolowska B et al (2013) Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg\u2013Strauss syndrome and granulomatosis with polyangiitis (Wegener\u2019s) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging 29:843\u2013853. doi: 10.1007\/s10554-012-0158-6","journal-title":"Int J Cardiovasc Imaging"},{"key":"3435_CR14","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00330-011-2203-6","volume":"21","author":"T Miszalski-Jamka","year":"2011","unstructured":"Miszalski-Jamka T, Szczeklik W, Sokolowska B et al (2011) Cardiac involvement in Wegener\u2019s granulomatosis resistant to induction therapy. Eur Radiol 21:2297\u20132304. doi: 10.1007\/s00330-011-2203-6","journal-title":"Eur Radiol"},{"key":"3435_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","volume":"42","author":"L Guillevin","year":"1999","unstructured":"Guillevin L, Durand-Gasselin B, Cevallos R et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421\u2013430","journal-title":"Arthritis Rheum"},{"key":"3435_CR16","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.4238\/2015.May.18.22","volume":"14","author":"ZW Shuai","year":"2015","unstructured":"Shuai ZW, Lv YF, Zhang MM, Hu ZY (2015) Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Genet Mol Res 14:5296\u20135303. doi: 10.4238\/2015.May.18.22","journal-title":"Genet Mol Res"},{"key":"3435_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/art.24695","volume":"61","author":"S Mavrogeni","year":"2009","unstructured":"Mavrogeni S, Manoussakis MN, Karagiorga TC et al (2009) Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Care Res (Hoboken) 61:1121\u20131129. doi: 10.1002\/art.24695","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3435_CR18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3899\/jrheum.120808","volume":"40","author":"S Gendelman","year":"2013","unstructured":"Gendelman S, Zeft A, Spalding SJ (2013) Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg\u2013Strauss syndrome): a contemporary single-center cohort. J Rheumatol 40:929\u2013935. doi: 10.3899\/jrheum.120808","journal-title":"J Rheumatol"},{"key":"3435_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","volume":"72","author":"F Moosig","year":"2013","unstructured":"Moosig F, Bremer JP, Hellmich B et al (2013) A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg\u2013Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 72:1011\u20131017. doi: 10.1136\/annrheumdis-2012-201531","journal-title":"Ann Rheum Dis"},{"key":"3435_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/art.27263","volume":"62","author":"RM Dennert","year":"2010","unstructured":"Dennert RM, Van Paassen P, Schalla S et al (2010) Cardiac involvement in Churg\u2013Strauss syndrome. Arthritis Rheum 62:627\u2013634. doi: 10.1002\/art.27263","journal-title":"Arthritis Rheum"},{"key":"3435_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ejim.2010.05.004","volume":"21","author":"J Vinit","year":"2010","unstructured":"Vinit J, Bielefeld P, Muller G et al (2010) Heart involvement in Churg\u2013Strauss syndrome: retrospective study in French Burgundy population in past 10 years. Eur J Intern Med 21:341\u2013346. doi: 10.1016\/j.ejim.2010.05.004","journal-title":"Eur J Intern Med"},{"key":"3435_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00281-014-0436-6","volume":"36","author":"EF McKinney","year":"2014","unstructured":"McKinney EF, Willcocks LC, Broecker V, Smith KGC (2014) The immunopathology of ANCA-associated vasculitis. Semin Immunopathol 36:461\u2013478. doi: 10.1007\/s00281-014-0436-6","journal-title":"Semin Immunopathol"},{"key":"3435_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fimmu.2014.00549","volume":"5","author":"A Gioffredi","year":"2014","unstructured":"Gioffredi A, Maritati F, Oliva E, Buzio C (2014) Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol 5:549. doi: 10.3389\/fimmu.2014.00549","journal-title":"Front Immunol"},{"key":"3435_CR24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/18715281113129990054","volume":"12","author":"S Mavrogeni","year":"2013","unstructured":"Mavrogeni S, Karabela G, Gialafos E et al (2013) Cardiac involvement in ANCA (+) and ANCA (\u2212) Churg\u2013Strauss syndrome evaluated by cardiovascular magnetic resonance. Inflamm Allergy Drug Targets 12:322\u2013327","journal-title":"Inflamm Allergy Drug Targets"},{"key":"3435_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/rheumatology\/kes155","volume":"52","author":"J Marmursztejn","year":"2013","unstructured":"Marmursztejn J, Guillevin L, Trebossen R et al (2013) Churg\u2013Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. Rheumatology (Oxford) 52:642\u2013650. doi: 10.1093\/rheumatology\/kes155","journal-title":"Rheumatology (Oxford)"},{"key":"3435_CR26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1253\/circj.CJ-10-0772","volume":"75","author":"W Szczeklik","year":"2011","unstructured":"Szczeklik W, Miszalski-Jamka T, Mastalerz L et al (2011) Multimodality assessment of cardiac involvement in Churg\u2013Strauss syndrome patients in clinical remission. Circ J 75:649\u2013655","journal-title":"Circ J"},{"key":"3435_CR27","first-page":"8","volume":"28","author":"J Marmursztejn","year":"2010","unstructured":"Marmursztejn J, Cohen P, Duboc D et al (2010) Cardiac magnetic resonance imaging in Churg\u2013Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patients. Clin Exp Rheumatol 28:8\u201313","journal-title":"Clin Exp Rheumatol"},{"key":"3435_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1540-8175.2011.01654.x","volume":"29","author":"T Miszalski-Jamka","year":"2012","unstructured":"Miszalski-Jamka T, Szczeklik W, Nycz K et al (2012) The mechanics of left ventricular dysfunction in patients with Churg\u2013Strauss syndrome. Echocardiography 29:568\u2013578. doi: 10.1111\/j.1540-8175.2011.01654.x","journal-title":"Echocardiography"},{"key":"3435_CR29","first-page":"1143","volume":"69","author":"W Szczeklik","year":"2011","unstructured":"Szczeklik W, Sokolowska BM, Mastalerz L et al (2011) QT dispersion in patients with Churg\u2013Strauss syndrome. Kardiol Pol 69:1143\u20131149","journal-title":"Kardiol Pol"},{"key":"3435_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.healun.2014.02.023","volume":"33","author":"M Groh","year":"2014","unstructured":"Groh M, Masciocco G, Kirchner E et al (2014) Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss syndrome). J Heart Lung Transplant 33:842\u2013850. doi: 10.1016\/j.healun.2014.02.023","journal-title":"J Heart Lung Transplant"},{"key":"3435_CR31","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/art.24957","volume":"60","author":"MD Morgan","year":"2009","unstructured":"Morgan MD, Turnbull J, Selamet U et al (2009) Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. Arthritis Rheum 60:3493\u20133500. doi: 10.1002\/art.24957","journal-title":"Arthritis Rheum"},{"key":"3435_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/hrt.2006.088443","volume":"93","author":"G Chironi","year":"2007","unstructured":"Chironi G, Pagnoux C, Simon A et al (2007) Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis. Heart 93:96\u201399. doi: 10.1136\/hrt.2006.088443","journal-title":"Heart"},{"key":"3435_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3899\/jrheum.130882","volume":"41","author":"B Terrier","year":"2014","unstructured":"Terrier B, Chironi G, Pagnoux C et al (2014) Factors associated with major cardiovascular events in patients with systemic necrotizing vasculitides: results of a longterm followup study. J Rheumatol 41:723\u2013729. doi: 10.3899\/jrheum.130882","journal-title":"J Rheumatol"},{"key":"3435_CR34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3346\/jkms.2006.21.4.591","volume":"21","author":"YD Bae","year":"2006","unstructured":"Bae YD, Choi HJ, Lee JC et al (2006) Clinical features of polyarteritis nodosa in Korea. J Korean Med Sci 21:591\u2013595","journal-title":"J Korean Med Sci"},{"key":"3435_CR35","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/0002-8703(85)90365-5","volume":"109","author":"ML Schrader","year":"1985","unstructured":"Schrader ML, Hochman JS, Bulkley BH (1985) The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart J 109:1353\u20131359","journal-title":"Am Heart J"},{"key":"3435_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-5273(97)00119-8","volume":"60","author":"N Gunal","year":"1997","unstructured":"Gunal N, Kara N, Cakar N et al (1997) Cardiac involvement in childhood polyarteritis nodosa. Int J Cardiol 60:257\u2013262","journal-title":"Int J Cardiol"},{"key":"3435_CR37","doi-asserted-by":"publisher","first-page":"e33442","DOI":"10.1371\/journal.pone.0033442","volume":"7","author":"B Zoller","year":"2012","unstructured":"Zoller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One 7:e33442. doi: 10.1371\/journal.pone.0033442","journal-title":"PLoS One"},{"key":"3435_CR38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.md.0000180793.80212.17","volume":"84","author":"A Bourgarit","year":"2005","unstructured":"Bourgarit A, Le Toumelin P, Pagnoux C et al (2005) Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg\u2013Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 84:323\u2013330","journal-title":"Medicine (Baltimore)"},{"key":"3435_CR39","first-page":"78","volume":"22","author":"PR Fortin","year":"1995","unstructured":"Fortin PR, Larson MG, Watters AK et al (1995) Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group\u2014a review of 45 cases. J Rheumatol 22:78\u201384","journal-title":"J Rheumatol"},{"key":"3435_CR40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","volume":"75","author":"L Guillevin","year":"1996","unstructured":"Guillevin L, Lhote F, Gayraud M et al (1996) Prognostic factors in polyarteritis nodosa and Churg\u2013Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75:17\u201328","journal-title":"Medicine (Baltimore)"},{"key":"3435_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1136\/archdischild-2014-307536","volume":"100","author":"S Singh","year":"2015","unstructured":"Singh S, Vignesh P, Burgner D (2015) The epidemiology of Kawasaki disease: a global update. Arch Dis Child 100:1084\u20131088. doi: 10.1136\/archdischild-2014-307536","journal-title":"Arch Dis Child"},{"key":"3435_CR42","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.amjcard.2014.09.004","volume":"114","author":"BK Han","year":"2014","unstructured":"Han BK, Lesser A, Rosenthal K et al (2014) Coronary computed tomographic angiographic findings in patients with Kawasaki disease. Am J Cardiol 114:1676\u20131681. doi: 10.1016\/j.amjcard.2014.09.004","journal-title":"Am J Cardiol"},{"key":"3435_CR43","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/circimaging.111.965996","volume":"4","author":"CE Tacke","year":"2011","unstructured":"Tacke CE, Kuipers IM, Groenink M, Spijkerboer AM, Kuijpers TW (2011) Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging 4:712\u2013720. doi: 10.1161\/circimaging.111.965996","journal-title":"Circ Cardiovasc Imaging"},{"key":"3435_CR44","first-page":"S126","volume":"29","author":"K Chaudhuri","year":"2011","unstructured":"Chaudhuri K, Singh Ahluwalia T, Singh S, Binepal G, Khullar M (2011) Polymorphism in the promoter of the CCL5 gene (CCL5G-403A) in a cohort of North Indian children with Kawasaki disease. A preliminary study. Clin Exp Rheumatol 29:S126\u2013S130","journal-title":"Clin Exp Rheumatol"},{"key":"3435_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.anpedi.2010.11.024","volume":"74","author":"FJ Caballero-Mora","year":"2011","unstructured":"Caballero-Mora FJ, Alonso-Martin B, Tamariz-Martel-Moreno A, Cano-Fernandez J, Sanchez-Bayle M (2011) Kawasaki disease in 76 patients. Risk factors for coronary artery aneurysms. An Pediatr (Barc) 74:232\u2013238. doi: 10.1016\/j.anpedi.2010.11.024","journal-title":"An Pediatr (Barc)"},{"key":"3435_CR46","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/INF.0b013e31825c4d7c","volume":"31","author":"LS Callinan","year":"2012","unstructured":"Callinan LS, Tabnak F, Holman RC et al (2012) Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J 31:894\u2013898. doi: 10.1097\/INF.0b013e31825c4d7c","journal-title":"Pediatr Infect Dis J"},{"key":"3435_CR47","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00246-011-0143-1","volume":"33","author":"JJ Kim","year":"2012","unstructured":"Kim JJ, Hong YM, Yun SW et al (2012) Assessment of risk factors for Korean children with Kawasaki disease. Pediatr Cardiol 33:513\u2013520. doi: 10.1007\/s00246-011-0143-1","journal-title":"Pediatr Cardiol"},{"key":"3435_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1824-7288-39-69","volume":"39","author":"F Falcini","year":"2013","unstructured":"Falcini F, Rigante D, Masi L et al (2013) Fibroblast growth factor 23 (FGF23) gene polymorphism in children with Kawasaki syndrome (KS) and susceptibility to cardiac abnormalities. Ital J Pediatr 39:69. doi: 10.1186\/1824-7288-39-69","journal-title":"Ital J Pediatr"},{"key":"3435_CR49","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s00246-013-0673-9","volume":"34","author":"G Giannouli","year":"2013","unstructured":"Giannouli G, Tzoumaka-Bakoula C, Kopsidas I et al (2013) Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period. Pediatr Cardiol 34:1476\u20131481. doi: 10.1007\/s00246-013-0673-9","journal-title":"Pediatr Cardiol"},{"key":"3435_CR50","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1097\/INF.0b013e31829dd45e","volume":"32","author":"Y Ruan","year":"2013","unstructured":"Ruan Y, Ye B, Zhao X (2013) Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China. Pediatr Infect Dis J 32:e397\u2013e402. doi: 10.1097\/INF.0b013e31829dd45e","journal-title":"Pediatr Infect Dis J"},{"key":"3435_CR51","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00296-014-3186-9","volume":"35","author":"LS Maric","year":"2015","unstructured":"Maric LS, Knezovic I, Papic N et al (2015) Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Rheumatol Int 35:1053\u20131058. doi: 10.1007\/s00296-014-3186-9","journal-title":"Rheumatol Int"},{"key":"3435_CR52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2188\/jea.JE20140128","volume":"25","author":"M Kuwabara","year":"2015","unstructured":"Kuwabara M, Yashiro M, Kotani K et al (2015) Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. J Epidemiol 25:189\u2013193. doi: 10.2188\/jea.JE20140128","journal-title":"J Epidemiol"},{"key":"3435_CR53","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1002\/art.39112","volume":"67","author":"Q Ye","year":"2015","unstructured":"Ye Q, Shao WX, Shang SQ et al (2015) A comprehensive assessment of the value of laboratory indices in diagnosing Kawasaki disease. Arthritis Rheumatol 67:1943\u20131950. doi: 10.1002\/art.39112","journal-title":"Arthritis Rheumatol"},{"key":"3435_CR54","doi-asserted-by":"publisher","first-page":"14762","DOI":"10.1038\/srep14762","volume":"5","author":"YJ Lin","year":"2015","unstructured":"Lin YJ, Chang JS, Liu X et al (2015) Genetic variants in PLCB4\/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan. Sci Rep 5:14762. doi: 10.1038\/srep14762","journal-title":"Sci Rep"},{"key":"3435_CR55","first-page":"459","volume":"49","author":"LL Zhao","year":"2011","unstructured":"Zhao LL, Wang YB, Suo L (2011) Meta-analysis of the risk factors for coronary artery lesion secondary to Kawasaki disease in Chinese children. Zhonghua Er Ke Za Zhi 49:459\u2013467","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"3435_CR56","doi-asserted-by":"publisher","first-page":"e38998","DOI":"10.1371\/journal.pone.0038998","volume":"7","author":"JM Orenstein","year":"2012","unstructured":"Orenstein JM, Shulman ST, Fox LM et al (2012) Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 7:e38998. doi: 10.1371\/journal.pone.0038998","journal-title":"PLoS One"},{"key":"3435_CR57","doi-asserted-by":"publisher","first-page":"e38635","DOI":"10.1371\/journal.pone.0038635","volume":"7","author":"IC Lin","year":"2012","unstructured":"Lin IC, Kuo HC, Lin YJ et al (2012) Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis. PLoS One 7:e38635. doi: 10.1371\/journal.pone.0038635","journal-title":"PLoS One"},{"key":"3435_CR58","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.imbio.2012.04.004","volume":"218","author":"IC Lin","year":"2013","unstructured":"Lin IC, Suen JL, Huang SK et al (2013) Dectin-1\/Syk signaling is involved in Lactobacillus casei cell wall extract-induced mouse model of Kawasaki disease. Immunobiology 218:201\u2013212. doi: 10.1016\/j.imbio.2012.04.004","journal-title":"Immunobiology"},{"key":"3435_CR59","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/ATVBAHA.110.216325","volume":"31","author":"H Nishio","year":"2011","unstructured":"Nishio H, Kanno S, Onoyama S et al (2011) Nod1 ligands induce site-specific vascular inflammation. Arterioscler Thromb Vasc Biol 31:1093\u20131099. doi: 10.1161\/ATVBAHA.110.216325","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3435_CR60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2188\/jea.JE20130048","volume":"23","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y, Aso E, Yashiro M et al (2013) Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009. J Epidemiol 23:429\u2013434","journal-title":"J Epidemiol"},{"key":"3435_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00246-013-0746-9","volume":"35","author":"E Niedra","year":"2014","unstructured":"Niedra E, Chahal N, Manlhiot C, Yeung RS, McCrindle BW (2014) Atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms. Pediatr Cardiol 35:89\u201392. doi: 10.1007\/s00246-013-0746-9","journal-title":"Pediatr Cardiol"},{"key":"3435_CR62","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3899\/jrheum.110877","volume":"39","author":"M Mori","year":"2012","unstructured":"Mori M, Imagawa T, Hara R et al (2012) Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series. J Rheumatol 39:864\u2013867. doi: 10.3899\/jrheum.110877","journal-title":"J Rheumatol"},{"key":"3435_CR63","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/s0140-6736(13)62298-9","volume":"383","author":"AH Tremoulet","year":"2014","unstructured":"Tremoulet AH, Jain S, Jaggi P et al (2014) Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet 383:1731\u20131738. doi: 10.1016\/s0140-6736(13)62298-9","journal-title":"Lancet"},{"key":"3435_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2010.08.070","volume":"154","author":"K Millar","year":"2012","unstructured":"Millar K, Manlhiot C, Yeung RS, Somji Z, McCrindle BW (2012) Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression. Int J Cardiol 154:9\u201313. doi: 10.1016\/j.ijcard.2010.08.070","journal-title":"Int J Cardiol"},{"key":"3435_CR65","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1620\/tjem.220.285","volume":"220","author":"S Adachi","year":"2010","unstructured":"Adachi S, Sakaguchi H, Kuwahara T et al (2010) High regression rate of coronary aneurysms developed in patients with immune Globulin-Resistant Kawasaki disease treated with steroid pulse therapy. Tohoku J Exp Med 220:285\u2013290. doi: 10.1620\/tjem.220.285","journal-title":"Tohoku J Exp Med"},{"key":"3435_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/heartjnl-2012-302126","volume":"99","author":"S Chen","year":"2013","unstructured":"Chen S, Dong Y, Yin Y, Krucoff MW (2013) Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart 99:76\u201382. doi: 10.1136\/heartjnl-2012-302126","journal-title":"Heart"},{"key":"3435_CR67","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1365-2559.2012.04332.x","volume":"61","author":"M Harada","year":"2012","unstructured":"Harada M, Yokouchi Y, Oharaseki T et al (2012) Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology 61:1156\u20131167. doi: 10.1111\/j.1365-2559.2012.04332.x","journal-title":"Histopathology"},{"key":"3435_CR68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/circimaging.112.976969","volume":"6","author":"CE Tacke","year":"2013","unstructured":"Tacke CE, Romeih S, Kuipers IM et al (2013) Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging 6:67\u201373. doi: 10.1161\/circimaging.112.976969","journal-title":"Circ Cardiovasc Imaging"},{"key":"3435_CR69","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/ehjci\/jet041","volume":"14","author":"RT McCandless","year":"2013","unstructured":"McCandless RT, Minich LL, Wilkinson SE et al (2013) Myocardial strain and strain rate in Kawasaki disease. Eur Heart J Cardiovasc Imaging 14:1061\u20131068. doi: 10.1093\/ehjci\/jet041","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3435_CR70","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0002-8703(88)90342-0","volume":"116","author":"F Ichida","year":"1988","unstructured":"Ichida F, Fatica NS, O\u2019Loughlin JE et al (1988) Correlation of electrocardiographic and echocardiographic changes in Kawasaki syndrome. Am Heart J 116:812\u2013819","journal-title":"Am Heart J"},{"key":"3435_CR71","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00296-009-1252-5","volume":"31","author":"SJ Ghelani","year":"2011","unstructured":"Ghelani SJ, Singh S, Manojkumar R (2011) QT interval dispersion in North Indian children with Kawasaki disease without overt coronary artery abnormalities. Rheumatol Int 31:301\u2013305. doi: 10.1007\/s00296-009-1252-5","journal-title":"Rheumatol Int"},{"key":"3435_CR72","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.echo.2012.03.003","volume":"25","author":"J Oyamada","year":"2012","unstructured":"Oyamada J, Toyono M, Shimada S, Aoki-Okazaki M, Takahashi T (2012) Altered central aortic elastic properties in Kawasaki disease are related to changes in left ventricular geometry and coronary artery aneurysm formation. J Am Soc Echocardiogr 25:690\u2013696. doi: 10.1016\/j.echo.2012.03.003","journal-title":"J Am Soc Echocardiogr"},{"key":"3435_CR73","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.echo.2013.05.015","volume":"26","author":"A AlHuzaimi","year":"2013","unstructured":"AlHuzaimi A, Al Mashham Y, Potts JE, De Souza AM, Sandor GG (2013) Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease. J Am Soc Echocardiogr 26:1084\u20131089. doi: 10.1016\/j.echo.2013.05.015","journal-title":"J Am Soc Echocardiogr"},{"key":"3435_CR74","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1136\/heartjnl-2015-307734","volume":"101","author":"V Shah","year":"2015","unstructured":"Shah V, Christov G, Mukasa T et al (2015) Cardiovascular status after Kawasaki disease in the UK. Heart 101:1646\u20131655. doi: 10.1136\/heartjnl-2015-307734","journal-title":"Heart"},{"key":"3435_CR75","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/01.CIR.90.4.1855","volume":"90","author":"K Ishikawa","year":"1994","unstructured":"Ishikawa K, Maetani S (1994) Long-term outcome for 120 Japanese patients with Takayasu\u2019s disease. Clinical and statistical analyses of related prognostic factors. Circulation 90:1855\u20131860","journal-title":"Circulation"},{"key":"3435_CR76","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1067\/mtc.2003.39","volume":"125","author":"M Endo","year":"2003","unstructured":"Endo M, Tomizawa Y, Nishida H et al (2003) Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg 125:570\u2013577. doi: 10.1067\/mtc.2003.39","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3435_CR77","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.amjcard.2013.11.045","volume":"113","author":"C Comarmond","year":"2014","unstructured":"Comarmond C, Cluzel P, Toledano D et al (2014) Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis. Am J Cardiol 113:881\u2013887. doi: 10.1016\/j.amjcard.2013.11.045","journal-title":"Am J Cardiol"},{"key":"3435_CR78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijcard.2011.01.094","volume":"159","author":"GY Lee","year":"2012","unstructured":"Lee GY, Jang SY, Ko SM et al (2012) Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol 159:14\u201320. doi: 10.1016\/j.ijcard.2011.01.094","journal-title":"Int J Cardiol"},{"key":"3435_CR79","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1532\/hsf98.20121059","volume":"16","author":"C Li","year":"2013","unstructured":"Li C, Liu Y, Qi R et al (2013) Repair of aortic regurgitation due to Takayasu arteritis. Heart Surg Forum 16:E24\u2013E26. doi: 10.1532\/hsf98.20121059","journal-title":"Heart Surg Forum"},{"key":"3435_CR80","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(94)93103-8","volume":"343","author":"R Misra","year":"1994","unstructured":"Misra R, Aggarwal A, Chag M, Sinha N, Shrivastava S (1994) Raised anticardiolipin antibodies in Takayasu\u2019s arteritis. Lancet 343:1644\u20131645","journal-title":"Lancet"},{"key":"3435_CR81","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/03009742.2014.964305","volume":"44","author":"NP Jordan","year":"2015","unstructured":"Jordan NP, Bezanahary H, D\u2019Cruz DP (2015) Increased risk of vascular complications in Takayasu\u2019s arteritis patients with positive lupus anticoagulant. Scand J Rheumatol 44:211\u2013214. doi: 10.3109\/03009742.2014.964305","journal-title":"Scand J Rheumatol"},{"key":"3435_CR82","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s002590100648","volume":"28","author":"M Castellani","year":"2001","unstructured":"Castellani M, Vanoli M, Cali G et al (2001) Ventilation-perfusion lung scan for the detection of pulmonary involvement in Takayasu\u2019s arteritis. Eur J Nucl Med 28:1801\u20131805. doi: 10.1007\/s002590100648","journal-title":"Eur J Nucl Med"},{"key":"3435_CR83","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3899\/jrheum.140436","volume":"42","author":"X Wang","year":"2015","unstructured":"Wang X, Dang A, Chen B, Lv N, Liu Q (2015) Takayasu arteritis-associated pulmonary hypertension. J Rheumatol 42:495\u2013503. doi: 10.3899\/jrheum.140436","journal-title":"J Rheumatol"},{"key":"3435_CR84","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3899\/jrheum.131007","volume":"41","author":"H Dong","year":"2014","unstructured":"Dong H, Jiang X, Peng M et al (2014) Percutaneous transluminal angioplasty for symptomatic pulmonary stenosis in Takayasu arteritis. J Rheumatol 41:1856\u20131862. doi: 10.3899\/jrheum.131007","journal-title":"J Rheumatol"},{"key":"3435_CR85","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.jacc.2011.11.080","volume":"60","author":"GB Kim","year":"2012","unstructured":"Kim GB, Kwon BS, Bae EJ, Noh CI (2012) Takayasu arteritis presenting as dilated cardiomyopathy with left ventricular thrombus in association with ulcerative colitis. J Am Coll Cardiol 60:e25. doi: 10.1016\/j.jacc.2011.11.080","journal-title":"J Am Coll Cardiol"},{"key":"3435_CR86","doi-asserted-by":"publisher","first-page":"763","DOI":"10.5543\/tkda.2014.60687","volume":"42","author":"T Seker","year":"2014","unstructured":"Seker T, Baykan AO, Borekci A, Gur M, Cayli M (2014) Successful treatment of a huge thrombus with thrombolytic therapy in a patient with normal left ventricle function and Takayasu arteritis. Turk Kardiyol Dern Ars 42:763\u2013766. doi: 10.5543\/tkda.2014.60687","journal-title":"Turk Kardiyol Dern Ars"},{"key":"3435_CR87","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3899\/jrheum.130162","volume":"40","author":"TF Silva da","year":"2013","unstructured":"da Silva TF, Levy-Neto M, Bonfa E, Pereira RM (2013) High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels. J Rheumatol 40:1897\u20131904. doi: 10.3899\/jrheum.130162","journal-title":"J Rheumatol"},{"key":"3435_CR88","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s00380-010-0101-5","volume":"26","author":"Y Matsue","year":"2011","unstructured":"Matsue Y, Ohno M, Nagahori W et al (2011) A case of giant cell arteritis with massive pericardial effusion. Heart Vessels 26:562\u2013564. doi: 10.1007\/s00380-010-0101-5","journal-title":"Heart Vessels"},{"key":"3435_CR89","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00380-011-0158-9","volume":"27","author":"T Kimura","year":"2012","unstructured":"Kimura T, Komura M, Okubo Y (2012) Atypical giant cell arteritis predominantly involving intramural coronary arteries: a case showing refractory dialysis-related hypotension. Heart Vessels 27:216\u2013220. doi: 10.1007\/s00380-011-0158-9","journal-title":"Heart Vessels"},{"key":"3435_CR90","doi-asserted-by":"publisher","first-page":"E137","DOI":"10.1532\/hsf98.20101114","volume":"14","author":"T Strecker","year":"2011","unstructured":"Strecker T, Zimmermann S, Wachter DL, Agaimy A (2011) Aortic dissection caused by giant cell arteritis. Heart Surg Forum 14:E137\u2013E138. doi: 10.1532\/hsf98.20101114","journal-title":"Heart Surg Forum"},{"key":"3435_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7326\/m12-3046","volume":"160","author":"G Tomasson","year":"2014","unstructured":"Tomasson G, Peloquin C, Mohammad A et al (2014) Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study. Ann Intern Med 160:73\u201380. doi: 10.7326\/m12-3046","journal-title":"Ann Intern Med"},{"key":"3435_CR92","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3899\/jrheum.121150","volume":"40","author":"J Schmidt","year":"2013","unstructured":"Schmidt J, Kermani TA, Muratore F et al (2013) Statin use in giant cell arteritis: a retrospective study. J Rheumatol 40:910\u2013915. doi: 10.3899\/jrheum.121150","journal-title":"J Rheumatol"},{"key":"3435_CR93","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.athoracsur.2010.12.068","volume":"92","author":"H Gasparovic","year":"2011","unstructured":"Gasparovic H, Djuric Z, Bosnic D et al (2011) Aortic root vasculitis associated with Cogan\u2019s syndrome. Ann Thorac Surg 92:340\u2013341. doi: 10.1016\/j.athoracsur.2010.12.068","journal-title":"Ann Thorac Surg"},{"key":"3435_CR94","first-page":"573","volume":"16","author":"T Weyn","year":"2009","unstructured":"Weyn T, Haine S, Conraads V (2009) Cogan\u2019s syndrome with left main coronary artery occlusion. Cardiol J 16:573\u2013576","journal-title":"Cardiol J"},{"key":"3435_CR95","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e3182428f49","volume":"91","author":"G Geri","year":"2012","unstructured":"Geri G, Wechsler B, Thi Huong du L et al (2012) Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 91:25\u201334. doi: 10.1097\/MD.0b013e3182428f49","journal-title":"Medicine (Baltimore)"},{"key":"3435_CR96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/rheumatology\/keu247","volume":"54","author":"NG Bonitsis","year":"2015","unstructured":"Bonitsis NG, Luong Nguyen LB, LaValley MP et al (2015) Gender-specific differences in Adamantiades\u2013Behcet\u2019s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology (Oxford) 54:121\u2013133. doi: 10.1093\/rheumatology\/keu247","journal-title":"Rheumatology (Oxford)"},{"key":"3435_CR97","first-page":"S87","volume":"32","author":"H Emmungil","year":"2014","unstructured":"Emmungil H, Yasar Bilge NS, Kucuksahin O et al (2014) A rare but serious manifestation of Behcet\u2019s disease: intracardiac thrombus in 22 patients. Clin Exp Rheumatol 32:S87\u2013S92","journal-title":"Clin Exp Rheumatol"},{"key":"3435_CR98","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1874192401004020071","volume":"4","author":"M Regina La","year":"2010","unstructured":"La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behcet\u2019s disease as a model of venous thrombosis. Open Cardiovasc Med J 4:71\u201377. doi: 10.2174\/1874192401004020071","journal-title":"Open Cardiovasc Med J"},{"key":"3435_CR99","first-page":"S27","volume":"30","author":"C Yue","year":"2012","unstructured":"Yue C, Li J, Li M et al (2012) Cardiac mass in Behcet\u2019s disease. Clin Exp Rheumatol 30:S27\u2013S31","journal-title":"Clin Exp Rheumatol"},{"key":"3435_CR100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1540-8191.2011.01392.x","volume":"27","author":"WG Ma","year":"2012","unstructured":"Ma WG, Zheng J, Zhu JM et al (2012) Aortic regurgitation caused by Behcet\u2019s disease: surgical experience during an 11-year period. J Card Surg 27:39\u201344. doi: 10.1111\/j.1540-8191.2011.01392.x","journal-title":"J Card Surg"},{"key":"3435_CR101","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5830\/CVJA-2014-003","volume":"25","author":"Z Ulusan","year":"2014","unstructured":"Ulusan Z, Karadag AS, Tasar M, Kalender M, Darcin OT (2014) Behcet\u2019s disease and cardiovascular involvement: our experience of asymptomatic Behcet\u2019s patients. Cardiovasc J Afr 25:63\u201366. doi: 10.5830\/CVJA-2014-003","journal-title":"Cardiovasc J Afr"},{"key":"3435_CR102","doi-asserted-by":"publisher","first-page":"160","DOI":"10.17305\/bjbms.2014.3.2","volume":"14","author":"S Demirelli","year":"2014","unstructured":"Demirelli S, Degirmenci H, Bilen H et al (2014) Left ventricular mechanics in Behcet\u2019s disease: a speckle tracking echocardiographic study. Bosn J Basic Med Sci 14:160\u2013164. doi: 10.17305\/bjbms.2014.3.2","journal-title":"Bosn J Basic Med Sci"},{"key":"3435_CR103","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/ejechocard\/jer088","volume":"12","author":"J Yagmur","year":"2011","unstructured":"Yagmur J, Sener S, Acikgoz N et al (2011) Subclinical left ventricular dysfunction in Behcet\u2019s disease assessed by two-dimensional speckle tracking echocardiography. Eur J Echocardiogr 12:536\u2013541. doi: 10.1093\/ejechocard\/jer088","journal-title":"Eur J Echocardiogr"},{"key":"3435_CR104","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/147323001204000133","volume":"40","author":"V Cobankara","year":"2012","unstructured":"Cobankara V, Guclu A, Kuru O et al (2012) Evaluation of biventricular myocardial performance index in patients with Behcet\u2019s disease. J Int Med Res 40:328\u2013332","journal-title":"J Int Med Res"},{"key":"3435_CR105","first-page":"29","volume":"39","author":"M Cansel","year":"2014","unstructured":"Cansel M, Yagmur J, Tasolar H et al (2014) Assessment of atrial conduction time in patients with Behcet\u2019s disease. Acta Reumatol Port 39:29\u201336","journal-title":"Acta Reumatol Port"},{"key":"3435_CR106","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/MCA.0b013e328361a978","volume":"24","author":"MR Sayin","year":"2013","unstructured":"Sayin MR, Akpinar I, Gursoy YC et al (2013) Assessment of QRS duration and presence of fragmented QRS in patients with Behcet\u2019s disease. Coron Artery Dis 24:398\u2013403. doi: 10.1097\/MCA.0b013e328361a978","journal-title":"Coron Artery Dis"},{"key":"3435_CR107","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ejechocard\/jer227","volume":"13","author":"T Karabag","year":"2012","unstructured":"Karabag T, Aydin M, Dogan SM et al (2012) Investigation of the atrial electromechanical delay duration in Behcet patients by tissue Doppler echocardiography. Eur Heart J Cardiovasc Imaging 13:251\u2013256. doi: 10.1093\/ejechocard\/jer227","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3435_CR108","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10067-011-1763-9","volume":"31","author":"P Borman","year":"2012","unstructured":"Borman P, Tuncay F, Kocaoglu S et al (2012) The subclinic autonomic dysfunction in patients with Behcet disease: an electrophysiological study. Clin Rheumatol 31:41\u201347. doi: 10.1007\/s10067-011-1763-9","journal-title":"Clin Rheumatol"},{"key":"3435_CR109","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000365139","volume":"129","author":"A Pandey","year":"2014","unstructured":"Pandey A, Garg J, Krishnamoorthy P et al (2014) Predictors of coronary artery disease in patients with Beh\u00e7et\u2019s disease. Cardiology (Switzerland) 129:203\u2013206. doi: 10.1159\/000365139","journal-title":"Cardiology (Switzerland)"},{"key":"3435_CR110","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.7863\/ultra.33.8.1393","volume":"33","author":"H Tasolar","year":"2014","unstructured":"Tasolar H, Tasolar S, Kurtulus D et al (2014) Increased epicardial adipose tissue thickness on transthoracic echocardiography in patients with Behcet disease. J Ultrasound Med 33:1393\u20131400. doi: 10.7863\/ultra.33.8.1393","journal-title":"J Ultrasound Med"},{"key":"3435_CR111","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jjcc.2011.09.004","volume":"59","author":"G Kocabay","year":"2012","unstructured":"Kocabay G, Hasdemir H, Yildiz M (2012) Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Behcet\u2019s disease. J Cardiol 59:72\u201377. doi: 10.1016\/j.jjcc.2011.09.004","journal-title":"J Cardiol"},{"key":"3435_CR112","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/jdv.12297","volume":"28","author":"I Balta","year":"2014","unstructured":"Balta I, Balta S, Koryurek OM et al (2014) Mean platelet volume is associated with aortic arterial stiffness in patients with Behcet\u2019s disease without significant cardiovascular involvement. J Eur Acad Dermatol Venereol 28:1388\u20131393. doi: 10.1111\/jdv.12297","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3435_CR113","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/03009740600938647","volume":"36","author":"C Botsios","year":"2007","unstructured":"Botsios C, Sfriso P, Punzi L, Todesco S (2007) Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra. Scand J Rheumatol 36:236\u2013237. doi: 10.1080\/03009740600938647","journal-title":"Scand J Rheumatol"},{"key":"3435_CR114","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1546-0096-9-21","volume":"9","author":"EM Boyer","year":"2011","unstructured":"Boyer EM, Turman M, O\u2019Neil KM (2011) Partial response to anakinra in life-threatening Henoch\u2013Sch\u00f6nlein purpura: case report. Pediatr Rheumatol Online J 9:21. doi: 10.1186\/1546-0096-9-21","journal-title":"Pediatr Rheumatol Online J"},{"key":"3435_CR115","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","volume":"141","author":"L Wei","year":"2004","unstructured":"Wei L, MacDonald TM, Walker BR (2004) Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764\u2013770","journal-title":"Ann Intern Med"},{"key":"3435_CR116","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/hrt.2003.020180","volume":"90","author":"PC Souverein","year":"2004","unstructured":"Souverein PC, Berard A, Van Staa TP et al (2004) Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90:859\u2013865. doi: 10.1136\/hrt.2003.020180","journal-title":"Heart"},{"key":"3435_CR117","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.atherosclerosis.2006.05.019","volume":"192","author":"C Varas-Lorenzo","year":"2007","unstructured":"Varas-Lorenzo C, Rodriguez LA, Maguire A, Castellsague J, Perez-Gutthann S (2007) Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis 192:376\u2013383. doi: 10.1016\/j.atherosclerosis.2006.05.019","journal-title":"Atherosclerosis"},{"key":"3435_CR118","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1751-7133.2011.00279.x","volume":"18","author":"S Dadfarmay","year":"2012","unstructured":"Dadfarmay S, Berkowitz R, Kim B (2012) Irreversible end-stage cardiomyopathy following a single dose of cyclophosphamide. Congest Heart Fail 18:234\u2013237. doi: 10.1111\/j.1751-7133.2011.00279.x","journal-title":"Congest Heart Fail"},{"key":"3435_CR119","first-page":"626","volume":"40","author":"N Agarwal","year":"2013","unstructured":"Agarwal N, Burkart TA (2013) Transient, high-grade atrioventricular block from high-dose cyclophosphamide. Tex Heart Inst J 40:626\u2013627","journal-title":"Tex Heart Inst J"},{"key":"3435_CR120","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3109\/10428194.2014.887711","volume":"55","author":"F Zhou","year":"2014","unstructured":"Zhou F, Ling C, Guo L et al (2014) Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed\/refractory multiple myeloma with severe heart failure. Leuk Lymphoma 55:2271\u20132276. doi: 10.3109\/10428194.2014.887711","journal-title":"Leuk Lymphoma"},{"key":"3435_CR121","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3899\/jrheum.111334","volume":"39","author":"S Ajeganova","year":"2012","unstructured":"Ajeganova S, de Faire U, Jogestrand T, Frostegard J, Hafstrom I (2012) Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis\u2014an inception cohort study. J Rheumatol 39:1146\u20131154. doi: 10.3899\/jrheum.111334","journal-title":"J Rheumatol"},{"key":"3435_CR122","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/jdv.12768","volume":"29","author":"O Ahlehoff","year":"2015","unstructured":"Ahlehoff O, Skov L, Gislason G et al (2015) Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. J Eur Acad Dermatol Venereol 29:1128\u20131134. doi: 10.1111\/jdv.12768","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3435_CR123","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","volume":"49","author":"SL Westlake","year":"2010","unstructured":"Westlake SL, Colebatch AN, Baird J et al (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 49:295\u2013307. doi: 10.1093\/rheumatology\/kep366","journal-title":"Rheumatology (Oxford)"},{"key":"3435_CR124","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","volume":"108","author":"R Micha","year":"2011","unstructured":"Micha R, Imamura F, Wyler von Ballmoos M et al (2011) Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol 108:1362\u20131370. doi: 10.1016\/j.amjcard.2011.06.054","journal-title":"Am J Cardiol"},{"key":"3435_CR125","doi-asserted-by":"publisher","DOI":"10.5152\/akd.2015.6136","author":"R Vecchis De","year":"2015","unstructured":"De Vecchis R, Baldi C, Palmisani L (2015) Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data. Anatol J Cardiol. doi: 10.5152\/akd.2015.6136","journal-title":"Anatol J Cardiol"},{"key":"3435_CR126","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206305","author":"CC Thornton","year":"2015","unstructured":"Thornton CC, Al-Rashed F, Calay D et al (2015) Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2014-206305","journal-title":"Ann Rheum Dis"},{"key":"3435_CR127","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/art.39039","volume":"67","author":"N Ronda","year":"2015","unstructured":"Ronda N, Greco D, Adorni MP et al (2015) Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism. Arthritis Rheumatol 67:1155\u20131164. doi: 10.1002\/art.39039","journal-title":"Arthritis Rheumatol"},{"key":"3435_CR128","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10557-013-6488-3","volume":"27","author":"A Bulgarelli","year":"2013","unstructured":"Bulgarelli A, Leite AC Jr, Dias AA, Maranhao RC (2013) Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits. Cardiovasc Drugs Ther 27:531\u2013539. doi: 10.1007\/s10557-013-6488-3","journal-title":"Cardiovasc Drugs Ther"},{"key":"3435_CR129","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000351972","volume":"126","author":"DM Moreira","year":"2013","unstructured":"Moreira DM, Lueneberg ME, da Silva RL, Fattah T, Mascia Gottschall CA (2013) Rationale and design of the TETHYS trial: the effects of methotrexate therapy on myocardial infarction with ST-segment elevation. Cardiology 126:167\u2013170. doi: 10.1159\/000351972","journal-title":"Cardiology"},{"key":"3435_CR130","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.atherosclerosis.2014.03.023","volume":"234","author":"L Zanoli","year":"2014","unstructured":"Zanoli L, Rastelli S, Inserra G et al (2014) Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs. Atherosclerosis 234:346\u2013351. doi: 10.1016\/j.atherosclerosis.2014.03.023","journal-title":"Atherosclerosis"},{"key":"3435_CR131","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1161\/atvbaha.110.205674","volume":"30","author":"TW Pols","year":"2010","unstructured":"Pols TW, Bonta PI, Pires NM et al (2010) 6-Mercaptopurine inhibits atherosclerosis in apolipoprotein e*3-leiden transgenic mice through atheroprotective actions on monocytes and macrophages. Arterioscler Thromb Vasc Biol 30:1591\u20131597. doi: 10.1161\/atvbaha.110.205674","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3435_CR132","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.transproceed.2009.03.045","volume":"41","author":"G Spagnoletti","year":"2009","unstructured":"Spagnoletti G, Citterio F, Favi E et al (2009) Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine. Transpl Proc 41:1175\u20131177. doi: 10.1016\/j.transproceed.2009.03.045","journal-title":"Transpl Proc"},{"key":"3435_CR133","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/ctr.12557","volume":"29","author":"V Cuervas-Mons","year":"2015","unstructured":"Cuervas-Mons V, Herrero JI, Gomez MA et al (2015) Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients. Clin Transplant 29:667\u2013677. doi: 10.1111\/ctr.12557","journal-title":"Clin Transplant"},{"key":"3435_CR134","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/annrheumdis-2011-200071","volume":"71","author":"SI Leuven van","year":"2012","unstructured":"van Leuven SI, Mendez-Fernandez YV, Wilhelm AJ et al (2012) Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(\u2212\/\u2212) mice. Ann Rheum Dis 71:408\u2013414. doi: 10.1136\/annrheumdis-2011-200071","journal-title":"Ann Rheum Dis"},{"key":"3435_CR135","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2174\/13816128113199990386","volume":"20","author":"AM Sijl van","year":"2014","unstructured":"van Sijl AM, van der Weele W, Nurmohamed MT (2014) Myocardial infarction after rituximab treatment for rheumatoid arthritis: is there a link? Curr Pharm Des 20:496\u2013499","journal-title":"Curr Pharm Des"},{"key":"3435_CR136","doi-asserted-by":"publisher","first-page":"288e","DOI":"10.1700\/1390.15471","volume":"99","author":"C Passalia","year":"2013","unstructured":"Passalia C, Minetto P, Arboscello E et al (2013) Cardiovascular adverse events complicating the administration of rituximab: report of two cases. Tumori 99:288e\u2013292e. doi: 10.1700\/1390.15471","journal-title":"Tumori"},{"key":"3435_CR137","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1177\/0961203314534909","volume":"23","author":"A Fernandez-Nebro","year":"2014","unstructured":"Fernandez-Nebro A, Marenco JL, Lopez-Longo F et al (2014) The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB). Lupus 23:1014\u20131022. doi: 10.1177\/0961203314534909","journal-title":"Lupus"},{"key":"3435_CR138","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/annrheumdis-2011-201228","volume":"72","author":"HG Raterman","year":"2013","unstructured":"Raterman HG, Levels H, Voskuyl AE et al (2013) HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab. Ann Rheum Dis 72:560\u2013565. doi: 10.1136\/annrheumdis-2011-201228","journal-title":"Ann Rheum Dis"},{"key":"3435_CR139","doi-asserted-by":"publisher","first-page":"e0130709","DOI":"10.1371\/journal.pone.0130709","volume":"10","author":"SA Provan","year":"2015","unstructured":"Provan SA, Berg IJ, Hammer HB et al (2015) The impact of newer biological disease modifying anti-rheumatic drugs on cardiovascular risk factors: a 12-month longitudinal study in rheumatoid arthritis patients treated with rituximab, abatacept and tociliziumab. PLoS One 10:e0130709. doi: 10.1371\/journal.pone.0130709","journal-title":"PLoS One"},{"key":"3435_CR140","doi-asserted-by":"publisher","first-page":"e001267","DOI":"10.1161\/jaha.114.001267","volume":"3","author":"PY Hsue","year":"2014","unstructured":"Hsue PY, Scherzer R, Grunfeld C et al (2014) Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis. J Am Heart Assoc 3:e001267. doi: 10.1161\/jaha.114.001267","journal-title":"J Am Heart Assoc"},{"key":"3435_CR141","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/bor.0000000000000004","volume":"26","author":"A Clifford","year":"2014","unstructured":"Clifford A, Hoffman GS (2014) Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies. Curr Opin Rheumatol 26:7\u201315. doi: 10.1097\/bor.0000000000000004","journal-title":"Curr Opin Rheumatol"},{"key":"3435_CR142","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/nejm199007263230405","volume":"323","author":"B Levine","year":"1990","unstructured":"Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236\u2013241. doi: 10.1056\/nejm199007263230405","journal-title":"N Engl J Med"},{"key":"3435_CR143","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.cir.0000077913.60364.d2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107:3133\u20133140. doi: 10.1161\/01.cir.0000077913.60364.d2","journal-title":"Circulation"},{"key":"3435_CR144","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1136\/annrheumdis-2012-202136","volume":"72","author":"DH Solomon","year":"2013","unstructured":"Solomon DH, Rassen JA, Kuriya B et al (2013) Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist. Ann Rheum Dis 72:1813\u20131818. doi: 10.1136\/annrheumdis-2012-202136","journal-title":"Ann Rheum Dis"},{"key":"3435_CR145","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/rheumatology\/keq316","volume":"50","author":"SL Westlake","year":"2011","unstructured":"Westlake SL, Colebatch AN, Baird J et al (2011) Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 50:518\u2013531. doi: 10.1093\/rheumatology\/keq316","journal-title":"Rheumatology (Oxford)"},{"key":"3435_CR146","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T et al (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74:480\u2013489. doi: 10.1136\/annrheumdis-2014-206624","journal-title":"Ann Rheum Dis"},{"key":"3435_CR147","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/art.38894","volume":"67","author":"A Souto","year":"2015","unstructured":"Souto A, Salgado E, Maneiro JR et al (2015) Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis Rheumatol 67:117\u2013127. doi: 10.1002\/art.38894","journal-title":"Arthritis Rheumatol"},{"key":"3435_CR148","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.atherosclerosis.2013.04.031","volume":"229","author":"AC Strang","year":"2013","unstructured":"Strang AC, Bisoendial RJ, Kootte RS et al (2013) Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis. Atherosclerosis 229:174\u2013181. doi: 10.1016\/j.atherosclerosis.2013.04.031","journal-title":"Atherosclerosis"},{"key":"3435_CR149","doi-asserted-by":"publisher","first-page":"e14328","DOI":"10.1371\/journal.pone.0014328","volume":"5","author":"O Schultz","year":"2010","unstructured":"Schultz O, Oberhauser F, Saech J et al (2010) Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One 5:e14328. doi: 10.1371\/journal.pone.0014328","journal-title":"PLoS One"},{"key":"3435_CR150","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3899\/jrheum.110340","volume":"38","author":"K Kume","year":"2011","unstructured":"Kume K, Amano K, Yamada S et al (2011) Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial. J Rheumatol 38:2169\u20132171. doi: 10.3899\/jrheum.110340","journal-title":"J Rheumatol"},{"key":"3435_CR151","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/acr.22455","volume":"67","author":"PE Lazzerini","year":"2015","unstructured":"Lazzerini PE, Acampa M, Capecchi PL et al (2015) Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation. Arthritis Care Res (Hoboken) 67:332\u2013339. doi: 10.1002\/acr.22455","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3435_CR152","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s10067-012-2034-0","volume":"31","author":"F Ursini","year":"2012","unstructured":"Ursini F, Mauro D, Naty S, Gagliardi D, Grembiale RD (2012) Improvement in insulin resistance after short-term treatment with abatacept: case report and short review. Clin Rheumatol 31:1401\u20131402. doi: 10.1007\/s10067-012-2034-0","journal-title":"Clin Rheumatol"},{"key":"3435_CR153","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1097\/md.0000000000000888","volume":"94","author":"F Ursini","year":"2015","unstructured":"Ursini F, Russo E, Letizia Hribal M et al (2015) Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. Medicine (Baltimore) 94:e888. doi: 10.1097\/md.0000000000000888","journal-title":"Medicine (Baltimore)"},{"key":"3435_CR154","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/btt.s52003","volume":"7","author":"S Mathieu","year":"2013","unstructured":"Mathieu S, Couderc M, Glace B et al (2013) Effects of 6\u00a0months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis. Biologics 7:259\u2013264. doi: 10.2147\/btt.s52003","journal-title":"Biologics"},{"key":"3435_CR155","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/TP.0b013e31820c10eb","volume":"91","author":"Y Vanrenterghem","year":"2011","unstructured":"Vanrenterghem Y, Bresnahan B, Campistol J et al (2011) Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies). Transplantation 91:976\u2013983. doi: 10.1097\/TP.0b013e31820c10eb","journal-title":"Transplantation"},{"key":"3435_CR156","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2337\/db15-0881","volume":"65","author":"C Nowak","year":"2016","unstructured":"Nowak C, Sundstrom J, Gustafsson S et al (2016) Protein biomarkers for insulin resistance and type 2 diabetes risk in two large community cohorts. Diabetes 65:276\u2013284. doi: 10.2337\/db15-0881","journal-title":"Diabetes"},{"key":"3435_CR157","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.imlet.2010.08.003","volume":"133","author":"JM Fragoso","year":"2010","unstructured":"Fragoso JM, Delgadillo H, Llorente L et al (2010) Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans. Immunol Lett 133:106\u2013111. doi: 10.1016\/j.imlet.2010.08.003","journal-title":"Immunol Lett"},{"key":"3435_CR158","doi-asserted-by":"publisher","first-page":"e37165","DOI":"10.1371\/journal.pone.0037165","volume":"7","author":"NB Johansen","year":"2012","unstructured":"Johansen NB, Vistisen D, Brunner EJ et al (2012) Determinants of aortic stiffness: 16-year follow-up of the Whitehall II study. PLoS One 7:e37165. doi: 10.1371\/journal.pone.0037165","journal-title":"PLoS One"},{"key":"3435_CR159","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1160\/th11-02-0117","volume":"106","author":"I Ikonomidis","year":"2011","unstructured":"Ikonomidis I, Tzortzis S, Lekakis J et al (2011) Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra. Thromb Haemost 106:959\u2013967. doi: 10.1160\/th11-02-0117","journal-title":"Thromb Haemost"},{"key":"3435_CR160","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/circulationaha.112.122556","volume":"126","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Howard CP, Walter V et al (2012) Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation 126:2739\u20132748. doi: 10.1161\/circulationaha.112.122556","journal-title":"Circulation"},{"key":"3435_CR161","first-page":"174","volume":"124","author":"PM Ridker","year":"2013","unstructured":"Ridker PM (2013) Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials? Trans Am Clin Climatol Assoc 124:174\u2013190","journal-title":"Trans Am Clin Climatol Assoc"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3435-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3435-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:28:35Z","timestamp":1559028515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3435-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,17]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["3435"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3435-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,17]]}}}